BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19349488)

  • 1. Adjuvant therapy for resected non-small cell lung cancer.
    Wozniak AJ; Gadgeel SM
    Ther Adv Med Oncol; 2009 Sep; 1(2):109-18. PubMed ID: 21789116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing patients with lung cancer. All evidence was considered when COIN guidelines were drawn up.
    Macbeth F
    BMJ; 2000 Jun; 320(7249):1604. PubMed ID: 10896438
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision medicine for adjuvant chemotherapy of resected colorectal cancer.
    Miyamoto Y; Hiyoshi Y; Sawayama H; Tokunaga R; Baba H
    Ann Gastroenterol Surg; 2020 Nov; 4(6):635-645. PubMed ID: 33319153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LACES and bootstraps: the hunt for prognostic and predictive markers for adjuvant therapy in NSCLC.
    Lee RC; Thapa B; John T
    Transl Lung Cancer Res; 2018 Sep; 7(Suppl 3):S239-S242. PubMed ID: 30393612
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploration of optimal time for initiating adjuvant chemotherapy after surgical resection: A retrospective study in Chinese patients with stage IIIA non-small cell lung cancer in a single center.
    Zhu Y; Zhai X; Chen S; Wang Z
    Thorac Cancer; 2016 Jul; 7(4):399-405. PubMed ID: 27385981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-guided drug delivery in lung cancer.
    Wiedmann TS; Sadhukha T; Hammer BE; Panyam J
    Drug Deliv Transl Res; 2012 Feb; 2(1):31-44. PubMed ID: 25786598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer.
    Zhi X; Gao W; Han B; Yang Y; Li H; Liu D; Wang C; Min G; Long H; Rigas JR; Carey M; Jahan T; Sammann A; Reza J; Wang D; Mann MJ; Jablons DM; He J;
    J Thorac Dis; 2013 Oct; 5(5):578-84. PubMed ID: 24255769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity.
    Castoldi R; Ecker V; Wiehle L; Majety M; Busl-Schuller R; Asmussen M; Nopora A; Jucknischke U; Osl F; Kobold S; Scheuer W; Venturi M; Klein C; Niederfellner G; Sustmann C
    Oncogene; 2013 Dec; 32(50):5593-601. PubMed ID: 23812422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer.
    Jiao W; Zhao J; Wang M; Wang Y; Luo Y; Zhao Y; Tang D; Shen Y
    Clin Transl Oncol; 2013 Oct; 15(10):789-95. PubMed ID: 23359188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based study.
    Lin ZZ; Shau WY; Shao YY; Yang YY; Kuo RN; Yang JC; Lai MS
    Oncologist; 2012; 17(10):1294-302. PubMed ID: 22826374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer.
    Baba T; Uramoto H; Kuwata T; Chikaishi Y; Nakagawa M; So T; Hanagiri T; Tanaka F
    Interact Cardiovasc Thorac Surg; 2012 Jun; 14(6):760-4. PubMed ID: 22374294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer histology, stage, treatment, and survival in American Indians and Alaska Natives and whites.
    Fesinmeyer MD; Goulart B; Blough DK; Buchwald D; Ramsey SD
    Cancer; 2010 Oct; 116(20):4810-6. PubMed ID: 20597131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy for lung cancer.
    Merk J; Leschber G
    Minerva Chir; 2009 Dec; 64(6):599-609. PubMed ID: 20029357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
    Erman M; Moretti L; Soria JC; Le Chevalier T; Van Houtte P
    Semin Radiat Oncol; 2004 Oct; 14(4):315-21. PubMed ID: 15558506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment of resected lung cancer.
    Chhatwani L; Cabebe E; Wakelee HA
    Proc Am Thorac Soc; 2009 Apr; 6(2):194-200. PubMed ID: 19349488
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.